Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone
Boris Michael Holzapfel,Boris Michael Holzapfel,Ferdinand Wagner,Daniela Loessner,Nina Pauline Holzapfel,Laure Thibaudeau,Ross Crawford,Ming-Tat Ling,Judith A. Clements,Pamela J. Russell,Dietmar W. Hutmacher,Dietmar W. Hutmacher,Dietmar W. Hutmacher +12 more
TL;DR: This model allows the analysis of interactions between human prostate cancer cells and a functional humanized bone organ within an immuno-incompetent murine host and can serve as a reproducible platform to study effects of therapeutics against prostate cancer bone metastases within a humanized microenvironment.
Journal ArticleDOI
Macrophage cathepsin K promotes prostate tumor progression in bone
Mackenzie K. Herroon,Erandi Rajagurubandara,Deborah Rudy,A Chalasani,Aimalie L. Hardaway,Izabela Podgorski +5 more
TL;DR: The data unravel novel roles for CTSK in macrophage-regulated processes, and provide evidence for close interplay between inflammatory, osteolytic and tumor cell-driven events in the bone–tumor microenvironment.
Journal ArticleDOI
Integrated Expression Profiling and ChIP-seq Analyses of the Growth Inhibition Response Program of the Androgen Receptor
Biaoyang Lin,Jun Wang,Xu Hong,Xiaowei Yan,Daehee Hwang,Ji-Hoon Cho,Danielle Yi,Angelita G. Utleg,Xuefeng Fang,Dustin E. Schones,Keji Zhao,Gilbert S. Omenn,Leroy Hood +12 more
TL;DR: The data provide a valuable data set in understanding the molecular basis for growth inhibition response program of the AR in prostate cancer cells, which can be exploited for developing novel prostate cancer therapeutic strategies.
Journal Article
Reversal of Radiation Resistance in LNCaP Cells by Targeting Apoptosis through Ceramide Synthase
Mark Garzotto,Adriana Haimovitz-Friedman,Wen Chieh Liao,Margaret White-Jones,Robert Huryk,Warren D. W. Heston,Carlos Cardon-Cardo,Richard Kolesnick,Zvi Fuks +8 more
TL;DR: This represents the first description of signaling-based therapy designed to overcome one form of radiation resistance expressed preferentially in LNCaP human prostate cancer cells by pretreatment with 12-O-tetradecanoylphorbol acetate (TPA).
Journal ArticleDOI
Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth
TL;DR: A low fat, high fiber diet and exercise intervention resulted in serum changes that significantly reduced the growth of androgen responsive LNCaP prostate cancer cells in vitro.